In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US agency opens offices in India

This article was originally published in SRA

Executive Summary

As part of its efforts to better guarantee the quality of food, drug and medical device imports, the US Food and Drug Administration has set up its first offices in India, in New Delhi and Mumbai1. The agency also recently opened offices in China, the European Union (in Brussels, Belgium), and in Latin America and there are plans to set up offices elsewhere in Latin America and also in the Middle East2,3.

You may also be interested in...



Isatuximab EU Approval Decision Due

Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.

Critical Juncture In Zolgensma EU Market Quest

If Zolgensma gets the thumbs up from the EMA this week, it will likely get formal EU approval within a couple of months. 

EU Approval Decision Delay For BMS’s Ozanimod

BMS should find out mid-2020 whether its new MS drug will be approved in the EU.

UsernamePublicRestriction

Register

MT038461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel